Expertise in
16
conditions

Alexander P. Grimm

Hoppe Seyler Str. 3, 
Tuebingen, BW, DE 
Expertise in
16
conditions
Hoppe Seyler Str. 3, 
Tuebingen, BW, DE 

Overview

Alexander Grimm practices practicing medicine in Tuebingen, Germany.

Mr. Grimm is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Chronic Inflammatory Demyelinating Polyneuropathy, Cramp-Fasciculation Syndrome, Radial Nerve Dysfunction, and Guillain-Barre Syndrome.

He is actively involved in clinical research, co-authoring 125 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Hoppe Seyler Str. 3, Tuebingen, BW 72076, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Genetic Screening of an At-risk Population for Hereditary TransthyRetin-related AMyloidosis and Longitudinal Monitoring of TTR Positive Subjects- A Multicenter Epidemiological Longitudinal Protocol
Genetic Screening of an At-risk Population for Hereditary TransthyRetin-related AMyloidosis and Longitudinal Monitoring of TTR Positive Subjects- A Multicenter Epidemiological Longitudinal Protocol
Enrollment Status: Completed
Publish Date: June 29, 2025
A Multi-center, Randomized, Double-blind, Placebo Controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A)
A Multi-center, Randomized, Double-blind, Placebo Controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A)
Enrollment Status: Unknown
Publish Date: April 03, 2024
Intervention Type: Drug
Study Drug: (RS)-Baclofen, Naltrexone Hydrochloride and D-Sorbitol
Study Phase: Phase 3
View 1 Less Clinical Trial

125 Total Publications

Millesi's Classification of Nerve Fibrosis Remains Underutilized in Modern Peripheral Nerve Research.
Millesi's Classification of Nerve Fibrosis Remains Underutilized in Modern Peripheral Nerve Research.
Journal: Muscle & nerve
Published: December 27, 2025

Frequently Asked Questions about Alexander P. Grimm

Is Alexander P. Grimm a top-rated expert for Chronic Inflammatory Demyelinating Polyneuropathy?

MediFind is an objective health platform that identifies experts based on real-world data. Alexander P. Grimm is classified as an Distinguished expert for Chronic Inflammatory Demyelinating Polyneuropathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Alexander P. Grimm participate in research or clinical trials?

Yes. Alexander P. Grimm has published 125 articles and abstracts on conditions like Chronic Inflammatory Demyelinating Polyneuropathy. You can view a list of Alexander P. Grimm's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Grimm's expertise for a condition
ConditionClose
    View All 14 Advanced Conditions
    View All 51 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile